Endometriosis could be diagnosed by blood test, research suggests

Researchers at the University of Edinburgh have identified a distinct hormonal signature in people with endometriosis, potentially enabling diagnosis through a simple blood test. The breakthrough addresses a major clinical gap, as endometriosis currently requires invasive surgery or imaging to confirm.

Endometriosis affects roughly 10 percent of reproductive-age women worldwide, causing tissue similar to the uterine lining to grow outside the uterus. The condition triggers chronic pain, infertility, and substantial quality-of-life impacts. Diagnosis delays are common, averaging seven to ten years from symptom onset, during which patients often cycle through ineffective treatments.

The Edinburgh team identified specific hormonal patterns distinguishing endometriosis patients from healthy controls. This finding shifts the diagnostic paradigm from invasive procedures to accessible blood screening. If validated in larger clinical trials, the test could accelerate diagnosis and enable earlier intervention.

The research aligns with broader efforts to improve endometriosis care. Diagnostic delays contribute to disease progression and psychological burden on patients who struggle for years to name their condition. A non-invasive blood test would democratize screening across healthcare settings, particularly in resource-limited regions where surgical diagnostics remain inaccessible.

Next steps involve clinical validation and determining whether the hormonal markers persist across diverse patient populations and disease stages. Regulatory approval and integration into standard clinical protocols would follow successful trials.

The discovery represents incremental progress in addressing a historically under-resourced condition. Investment in endometriosis research has historically lagged compared to conditions affecting similar populations, despite substantial morbidity. Blood-based biomarkers represent a practical diagnostic tool that could reshape patient outcomes and reduce the diagnostic odyssey that defines current endometriosis care.